DarioHealth Corp.
DarioHealth Corp. (DRIO) Revenue
Annual & quarterly revenue history · segment & region breakdown
DRIO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsDarioHealth Corp. trailing twelve-month (TTM) revenue is $0.02B, a decrease of 17.31% year-over-year from $0.02B in FY2025.
Revenue trend
2025 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.02B | -$0.00B | -17.31% |
| 2024-12-31 | $0.03B | +$0.01B | +32.86% |
| 2023-12-31 | $0.02B | -$0.01B | -26.41% |
| 2022-12-31 | $0.03B | +$0.01B | +34.82% |
| 2021-12-31 | $0.02B | +$0.01B | +170.76% |
| 2020-12-31 | $0.01B | +$0.00B | +0.22% |
| 2019-12-31 | $0.01B | +$0.00B | +2.23% |
| 2018-12-31 | $0.01B | +$0.00B | +43.02% |
| 2017-12-31 | $0.01B | +$0.00B | +84.45% |
| 2016-12-31 | $0.00B | +$0.00B | +240.58% |
Compare revenue vs peers
Medical - Diagnostics & ResearchCompare DRIO revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income DarioHealth Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
DarioHealth Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from DarioHealth Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
DRIO revenue · 4 questionsDRIO's trailing twelve-month (TTM) revenue is $0.02B. That is a decrease of 17.31% year-over-year from $0.02B in FY2025.
▸ Source: FMP · DarioHealth Corp. SEC filings · GAAP · DarioHealth Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026